Should I buy or sell Xyratex stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Xyratex in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" XRTX shares. View XRTX analyst ratings or view top-rated stocks .

What is Xyratex's stock price target for 2024?

1 brokers have issued 1 year price objectives for Xyratex's shares. Their XRTX share price targets range from $14.00 to $14.00. On average, they expect the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 369.8% from the stock's current price. View analysts price targets for XRTX or view top-rated stocks among Wall Street analysts .

Are investors shorting Xyratex?

Xyratex saw a increase in short interest in March. As of March 31st, there was short interest totaling 21,100 shares, an increase of 101.0% from the March 15th total of 10,500 shares. Based on an average trading volume of 51,100 shares, the short-interest ratio is currently 0.4 days. Approximately 1.2% of the company's stock are short sold. View Xyratex's Short Interest .

When is Xyratex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our XRTX earnings forecast .

When did Xyratex's stock split?

Xyratex's stock reverse split on the morning of Friday, November 10th 2023. The 1-9 reverse split was announced on Friday, November 10th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 11 shares after the split.

What other stocks do shareholders of Xyratex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Xyratex investors own include Encore Wire (WIRE) , Vishay Intertechnology (VSH) , Skyworks Solutions (SWKS) , SandRidge Energy (SD) , NVIDIA (NVDA) , Marvell Technology (MRVL) , MIPS Technologies (MIPS) , Ford Motor (F) and EMC (EMC) .

NASDAQ:XRTX

Xyratex (XRTX) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free XRTX Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $2.91
▼
$3.00
50-Day Range: N/A
52-Week Range: N/A

Volume: 13,010 shs
Average Volume: 37,113 shs
Market Capitalization: $5.96 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $14.00

Stock Analysis Analyst Forecasts Competitors Earnings Headlines Short Interest Social Media

Get Xyratex alerts:

Xyratex MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 369.8% Upside
$14.00 Price Target
Short Interest: Healthy
1.18% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.70 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Xyratex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Xyratex has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.18% of the float of Xyratex has been sold short.
Short Interest Ratio / Days to Cover
Xyratex has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Xyratex has recently increased by 100.95%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Xyratex does not currently pay a dividend.
Dividend Growth
Xyratex does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for XRTX.

0.0

News and Social Media Coverage

Search Interest
Only 1 people have searched for XRTX on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Xyratex insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 6.90% of the stock of Xyratex is held by insiders.
Percentage Held by Institutions
Only 0.23% of the stock of Xyratex is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Xyratex is -2.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Xyratex is -2.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Xyratex has a P/B Ratio of 1.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto Swap Profits

Did You Get Your Free Bitcoin Yet?

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About Xyratex Stock (NASDAQ:XRTX)

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.

Ad Crypto Swap Profits

Did You Get Your Free Bitcoin Yet?

>> Register right here

XRTX Stock News Headlines

April 8, 2024 | globenewswire.com

XORTX Welcomes New Member to the Board of Directors

April 5, 2024 | morningstar.com

XORTX Therapeutics Inc XRTX

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

April 1, 2024 | nasdaq.com

XORTX Therapeutics Inc. Common Stock (XRTX)

March 27, 2024 | globenewswire.com

XORTX Announces New Clinical Advisory Board Member

March 19, 2024 | finance.yahoo.com

XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial

March 19, 2024 | globenewswire.com

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

March 11, 2024 | finance.yahoo.com

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

March 4, 2024 | globenewswire.com

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

February 15, 2024 | finance.yahoo.com

XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units

February 2, 2024 | finance.yahoo.com

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

January 15, 2024 | finance.yahoo.com

XORTX Announces $2 Million Public Offering

January 5, 2024 | benzinga.com

XORTX Therapeutics Stock (NASDAQ:XRTX), Analyst Ratings, Price Targets, Predictions

January 3, 2024 | finance.yahoo.com

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

November 30, 2023 | finance.yahoo.com

XORTX Announces US ATM Offering

November 29, 2023 | finance.yahoo.com

XORTX Meets Nasdaq Continued Listing Requirements

November 10, 2023 | finance.yahoo.com

XORTX Clarifies Timing for Share Consolidation

November 8, 2023 | finance.yahoo.com

XORTX Announces Share Consolidation

November 2, 2023 | finance.yahoo.com

XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023

October 27, 2023 | finance.yahoo.com

XORTX Announces Results of Special Meeting of Shareholders

October 25, 2023 | finance.yahoo.com

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

October 25, 2023 | finance.yahoo.com

XORTX Announces Rescheduling of Special Meeting of Shareholders

October 4, 2023 | finance.yahoo.com

XORTX Calls Special Meeting of Shareholders

September 28, 2023 | finance.yahoo.com

XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023

September 7, 2023 | finance.yahoo.com

XORTX Joins the Kidney Foundation and Kidney March

August 29, 2023 | finance.yahoo.com

XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease

See More Headlines

Receive XRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xyratex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:XRTX
CUSIP: N/A
CIK: 1284823
Web: www.xyratex.com
Phone: +44-23-92496000
Fax: N/A
Employees: N/A
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $14.00
High Stock Price Target: $14.00
Low Stock Price Target: $14.00
Potential Upside/Downside: +369.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.0902)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-2,160,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -85.33%
Return on Assets: -78.45%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 13.79
Quick Ratio: 9.43

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.32 per share
Price / Book: 1.28

Miscellaneous

Outstanding Shares: 2,000,000
Free Float: 1,861,000
Market Cap: $5.96 million
Optionable: Not Optionable
Beta: 0.61

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Ernest J. Sampias (Age 62)
Interim Chief Executive Officer, Director
Richard Pearce (Age 42)
Chief Financial Officer, Director
Kenneth Todd Gresham (Age 55)
Senior Vice President - Marketing, Sales and Field Support
Doug Inamine (Age 47)
Senior Vice President - Human Resources
Luciano Marinaccio (Age 47)
Senior Vice President - Global Operations
Ed Prager (Age 48)
Senior Vice President - Research and Development
Ahmed Shihab (Age 42)
Senior Vice President - Business Line Management
Jonathan Brooks (Age 61)
Non-Executive Independent Chairman of the Board
Vadim Perelman (Age 33)
Director
Ken Traub
Director

Key Competitors

View All Competitors

XRTX Stock Analysis - Frequently Asked Questions

Should I buy or sell Xyratex stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Xyratex in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" XRTX shares.
View XRTX analyst ratings or view top-rated stocks.
What is Xyratex's stock price target for 2024?: 1 brokers have issued 1 year price objectives for Xyratex's shares. Their XRTX share price targets range from $14.00 to $14.00. On average, they expect the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 369.8% from the stock's current price.
View analysts price targets for XRTX or view top-rated stocks among Wall Street analysts.
Are investors shorting Xyratex?: Xyratex saw a increase in short interest in March. As of March 31st, there was short interest totaling 21,100 shares, an increase of 101.0% from the March 15th total of 10,500 shares. Based on an average trading volume of 51,100 shares, the short-interest ratio is currently 0.4 days. Approximately 1.2% of the company's stock are short sold.
View Xyratex's Short Interest.
When is Xyratex's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our XRTX earnings forecast.

When did Xyratex's stock split?: Xyratex's stock reverse split on the morning of Friday, November 10th 2023. The 1-9 reverse split was announced on Friday, November 10th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 11 shares after the split.
What other stocks do shareholders of Xyratex own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Xyratex investors own include Encore Wire (WIRE), Vishay Intertechnology (VSH), Skyworks Solutions (SWKS), SandRidge Energy (SD), NVIDIA (NVDA), Marvell Technology (MRVL), MIPS Technologies (MIPS), Ford Motor (F) and EMC (EMC).

This page (NASDAQ:XRTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Xyratex (XRTX) Stock Price, News & Analysis

Xyratex MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

Company Ownership

Earnings and Valuation

About Xyratex Stock (NASDAQ:XRTX)

XRTX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

XRTX Stock Analysis - Frequently Asked Questions

Overall MarketRank^™